News

OTTAWA, December 2, 2003 (LifeSiteNews.com) – Writing on behalf of the pro-life arm of the Canadian Conference of Catholic Bishops, Baie Comeau Bishop Pierre Morissette sent concerns to Health Minister Anne McLellan Thursday over the Government’s plan to allow the morning after pill over the counter in pharmacies.

Bishop Morissette, the Chairperson of the Catholic Organization for Life and Family (COLF), told the Health Minister that it is “inaccurate to refer to this pill as emergency contraception, given its potential to act as an abortifacient.”  He continued, “Women have a right to know that what is described as “emergency contraception” may in reality be a form of early abortion.”  The letter concludes, “Given that the morning after pill may act as an abortifacient, and because it may pose physical risks to women without in any way addressing the emotional and psychological distress they may be experiencing, we ask you to reconsider the proposal to make the morning after pill available ‘over the counter’.  How can it possibly be in the best interests of Canadian women to make this pill widely available without accurate information from Health Canada and without adequate safeguards for women and their unborn children.”  See the full COLF letter at:  https://colf.cccb.ca/PublicStatements.htm?CD=&ID=489

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.